Anti-anaerobic activity of secnidazole revisited;Le secnidazole: Activité antibactérienne sur les anaérobies stricts

Antibiotiques

Volumn 7, Issue 4, 2005, Pages 239-246

  Dubreuil, L ^a   Calvet, L ^a   Behra, J ^a  

^a UNIV LILLE   (France)

Author keywords

Anaerobes; Metronidazole; Secnidazole

Indexed keywords

AGAR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN; METRONIDAZOLE; SECNIDAZOLE;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BRUCELLA; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DILUTION; FUSOBACTERIUM; GRAM POSITIVE BACTERIUM; GRAM POSITIVE COCCI; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; PROPIONIBACTERIUM;

EID: 29544448638     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1294-5501(05)80457-1     Document Type: Article

References (31)

1. VIDEAU D, NIEL G, SIBOULET A et al. Secnidazole. A 5-nitroimidazole derivative with a long half-life. British J. Veneral diseases 1978 ; 54 : 77-80.
2. SARACOGLU F, GOL K, SAHIN I et al. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole. Int J Gynaecol Obstet 1998 ; 62 : 59-61.
3. AHUJA V, DHAR A, BAL C et al. Lansoprazole and secnidazole with clarithromycin amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Aliment Pharmacol Ther 1998 ; 12 : 551-5.
4. GILLIS JC, WISEMAN LR. Secnidazole. A review of its antimicrobial activity, pharmacodynamic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs 1996 ; 51 : 621-38.
5. RAO PS, SHIVANANDA PG. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents. Indian J Pathol Microbiol 2000 ; 43 :139-42.
6. DUBREUILL, BREUIL J, DUBLANCHET A. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992. Eur J Clin Microbiol Infect Dis 1992 ; 11 : 1094-9.
7. GROLLIER G, MORY F, QUENTIN C et al. Survey of anaerobic susceptibility patterns: A French multicentric study. Path Biol 1994 ; 42 : 498-504.
8. MORY F, LOCZNIEWSKI A, BLAND S et al. Survey of anaerobic susceptibility patterns : a French multicentric study. Int J Antimicrob Agents 1998 ; 10 : 229-36.
9. DUBREUIL L, SINGER E, ODOU MF et al. Anti-anaerobic activity of grepafloxacin compared with those of ofloxacin, ciprofloxacin, clindamycin, metronidazole and 5 β-lactams. Drugs 1999 ; 58 : 110-2.
10. DUBREUIL L, SINGER E, JAULHAC B et al. Sensibilité des anaérobies stricts aux antibiotiques. Antibiotiques 1999 ; 1 : 147-53.
11. BEHRA-MIELLET J, DUBREUIL L, JUMAS-BILAK E. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams Int J Antimicrob Agents 2002 ; 20 : 366-74.
12. BEHRA-MIELLET J, DUBREUIL LJ and the anaeroclub. Anaerobes : lesson from a French multicentric surveys. Anaerobe 2002 : 8 : 140.
13. BEHRA-MIELLET J, CALVET L, MORY F et al. Antibiotic Resistance Among Anaerobic Gram negative bacilli : Lessons from A French Multicentric Survey. Anaerobe 2003 ; 9 : 105-11.
14. LIEBETRAU A, RODLOFF AC, BEHRA-MIELLET J et al. In vitro evaluation of a new desfluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Antimicrob Agents Chemother 2003 ; 47 : 3667-71.
15. ALDRIDGE KE, ASHCRAFT D, CAMBRE K et al. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas and Peptostreptococcus spedes. Antimicrob Agents Chemother 2001 ; 45 : 1238-41.
16. HEDBERG M, NORD E, DUBREUIL L on behalf the ESCMID study group on antimicrobial resistance. Clinical Microbiology Infection 2003 ; 9 : 475-88.
17. DUBLANCHET A, CAILLON J, EDMOND JP. Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol 1986 ; 5 : 346-7.
18. National Committee for Clinical Laboratory Standards 2000. Methods for antimicrobial testing of anaerobic bacteria. Approved standard, fifth edition NCCLS publication M11-A5. National Committee for Clinical Laboratory Standards, Villanova Pa.
19. Ericsson HM, Sherris JC. Antibiotic susceptibility testing report of an international collaborative study. Acta Pathol Microbiol Scand, sect B, Microbiol Immunol 1971 ; suppl27 : 1-90.
20. Soussy CJ et al. Comité de l'Antibiogramme de la Société Française de Microbiologie Report 2003. Int J Antimicrob Agents 2003 ; 21 : 364-91.
21. JOKIPII L, JOKIPII AM. Comparative evaluation of the 2-methyl-5- nitroimidazole compounds, dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole and panidazole againts Bacteroides fragilis and other bacteria of the Bacteroides fragilis group. Antimicrob Agents Chemother 1985 ; 28 : 561-64.
22. MARCHANDIN H, JUMASBILAK E, TEYSSIER C, et al. Detection of nim genes in clinical isolates of Veillonella and Bacteroides fragilis in France. Anaerobe 2002 ; 8 : 137.
23. TRINH S, REYSSET G. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp. J Clin Microbiol 1996 ; 34 : 2078-84.
24. ELSAGHIER AA, BRAZIER JS, JAMES EA. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole. J Antimicrob Chemother 2003 ; 51 : 1436-7.
25. SANDOE JAT, STRUTHERS JK, BRAZIER JS. Subdural empyema caused by Prevotella loescheii with reduced susceptibility to metronidazole. J Antimicrob Chemother 2001 ; 47 : 366-7.
26. DUBREUIL L, BEHRA-MIELLET J, VOUILLOT C et al. β-lactamase production in Prevotella and in vitro susceptibilities to selected beta-lactam antibiotics. Int J Antimicrob Agents 2003 ; 21 : 267-73.
27. RYLANDER M, NORD CE, NORRBY SR. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anerobic bacteria. Eur J Clin Microbiol Infect Dis 1989 ; 8 : 919-24.
28. WOOTTON M, BOWKER KE, HOLT HA et al. BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials. J Antimicrob Chemother 2002 ; 49 : 535-9.
29. WEXLER HM, MOLITORIS E, FINEGOLD SM. In vitro activities of two new glycylcyclines, N, N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria. Antimicrob Agents Chemother 1994 ; 38 : 2513-5.
30. LUBBE MM, STANLEY K, CHALKLEY LJ. Prevalence of nim genes in anaerobic/facultative anaerobic bacteria isolated in South Africa. FEMS Microbiology Letters 1999 ; 172 : 79-83.
31. National Committee for Clinical Laboratory Standards 2004. Methods for antimicrobial testing of anaerobic bacteria. Approved standard, fifth edition NCCLS publication M11-A6. National Committee for Clinical Laboratory Standards, Villanova Pa.